Strategic objectives

• To advance the understanding of ischemic stroke.
• To develop pharmacological strategies with therapeutic potential to improve functional recovery after ischemic stroke.
• Treatment of strokes in the acute phase.
• To develop neurophysiological techniques for the prevention of nervous system damage in high-risk situations.

Research lines

Lines of clinical research:

• Secondary prevention in stroke.
• Reperfusion therapies in cerebral infarction. Use of neuroprotective drugs.
• Unusual causes of stroke. Carotid artery web.
• Recurrent cardioembolic stroke. New indications for left atrial appendage closure. Carotid filters.
• Factor XI inhibitors in non-cardioembolic stroke.
• Analysis of thrombi removed by mechanical thrombectomy.
• Evaluation and programming of deep brain stimulation systems and their effect on balance and gait in patients.
• Impact of neurophysiological monitoring for neuroprotection.

Lines of experimental research:

• Mechanisms of cell death and neuroprotection in cerebral ischemia.
• Identification of biomarkers sensitive to resistance and vulnerability in cerebral ischemia.
• Development of new neuroprotective drugs for cerebral ischemia.
• Study of non-excitatory amino acid transporters as novel molecular targets in cerebral ischemia-induced damage.